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Sonographically Guided Core Needle
Biopsy of Cervical Lymphadenopathy
in Patients Without Known Malignancy
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Objective. The purpose of this study was to retrospectively evaluate the efficacy of sonographically
guided core needle biopsy (core biopsy) for diagnosing the causes of cervical lymphadenopathy in
patients without known malignancy. Methods. One hundred fifty-five sonographically guided core
biopsies performed in 155 patients with cervical lymphadenopathy were retrospectively evaluated.
None of the 155 patients had any known primary malignancy. Final diagnoses were determined by the
histologic examination from excision biopsy when performed or by the clinical and sonographic fol-
low-up for more than 12 months. When a lymph node diagnosed as benign by sonographically guid-
ed core biopsy regressed spontaneously or by subsequent management, the diagnosis made by the
sonographically guided core biopsy was considered correct. When a lymph node diagnosed as benign
by sonographically guided core biopsy was unchanged or increased in size with subsequent manage-
ment, excision biopsy was performed. Diagnostic yield, sensitivity, specificity, accuracy, and complica-
tions of core biopsy were evaluated. Results. Histologic diagnosis could be made by sonographically
guided core biopsy in 146 (94%) of the 155 patients. The histologic diagnoses were reactive hyper-
plasia in 44 patients, tuberculosis in 37, Kikuchi disease in 25, metastasis in 16, lymphoma in 16, nor-
mal in 7, and toxoplasmosis in 1. Sensitivity, specificity, and accuracy of sonographically guided core
biopsy were 97.9%, 99.1%, and 97.9%, respectively. There were no procedure-related complications.
Conclusions. Sonographically guided core biopsy is a safe and efficient tool for diagnosing the cause
of cervical lymphadenopathy in patients without known malignancy and may obviate unnecessary
excisional biopsy. Key words: core biopsy; lymph node; neck mass; sonography. 
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Abbreviations
FNAC, fine-needle aspiration cytologic examination ervical lymphadenopathy can arise either from
benign or from malignant causes. For assess-
ment of cervical lymphadenopathy, fine-needle
aspiration cytologic examination (FNAC) is
widely used. The reported diagnostic accuracy of FNAC
in malignant lymphadenopathy ranges from 79% to
94.5%,1–3 but limitations of FNAC include a high rate of
nondiagnostic sampling, a high rate of false-negative
diagnoses in Hodgkin disease, and incomplete classifi-
cation of non-Hodgkin lymphoma.4,5 When FNAC for
unexplained cervical lymphadenopathy results in a non-
diagnostic or an equivocal report, excision biopsy may be
required. However, excision biopsy requires hospital
admission, at times may need general anesthesia, and
may even result in adverse outcomes.6
© 2007 by the American Institute of Ultrasound in Medicine • J Ultrasound Med 2007; 26:585–591 • 0278-4297/07/$3.50
C
Article
26.5.jum555-702.online.q  4/13/07  10:49 AM  Page 585
Sonographically guided core needle biopsy
(core biopsy) provides a larger tissue sample that
retains its architecture and permits the use of a
range of histochemical and immunohistochemi-
cal staining. Therefore, a more precise histologic
assessment can be made to diagnose the causes
of cervical lymphadenopathy. A few studies
reported that sonographically guided core biop-
sy in assessment of cervical lymphadenopathy
was a safe and accurate procedure in differentiat-
ing benign causes from malignancies.7,8
The purpose of this study was to retrospective-
ly evaluate the efficacy of sonographically guided
core biopsy for diagnosing the causes of cervical
lymphadenopathy in patients without known
malignancy.
Materials and Methods
The Institutional Review Board approved this
retrospective study, and informed consent was
not required. The results of 155 consecutive
sonographically guided core biopsies per-
formed in 155 patients between March 2000
and September 2005 were retrospectively evalu-
ated. The patients’ ages ranged from 13 to 82
years (mean, 38 years). All biopsies were per-
formed as part of an evaluation of patients with
unexplained cervical lymphadenopathy for 1 to
6 months. Inclusion criteria for sonographically
guided core biopsy were as follows: (1) unex-
plained cervical lymphadenopathy either on
physical examination or on an imaging study for
more than 1 month, (2) no known malignancy,
and (3) a short diameter of the lymph node of 1.0
cm or greater. Sonographic morphologic criteria
regarding a benign or malignant appearance
were not used for determination of the necessity
for core biopsy. Platelet counts and coagulation
times were not routinely checked. None of the
patients were premedicated. All sonographically
guided core biopsies were performed by 1 of the
2 staff radiologists on an outpatient basis.
Sonographic evaluation of the neck was per-
formed with a 7.5- to 10-MHz linear array trans-
ducer (HDI 5000; Philips Medical Systems,
Bothell, WA). A color Doppler study was routine-
ly used to identify the location of intervening ves-
sels. For core biopsy, the probe was covered with
sterilized vinyl. The skin was sterilized with povi-
done-iodide, which was also used as an acoustic
couplant. After local anesthesia with 1% lido-
caine, a tiny incision was made on the skin. Core
biopsy was performed under sonographic guid-
ance by a freehand technique (Figure 1) with a
disposable 16-gauge single-action automatic
core biopsy needle (Pro-Mag 2.2; Manan Medical
Products, Northbrook, IL) or a 16-gauge dual-
action semiautomatic core biopsy needle
(Stericut; TSK Laboratory, Tochigi, Japan). The
throw of both biopsy needles used was 2.2 cm.
Core biopsy was repeated until an adequate
amount of specimen was obtained on visual
inspection. We used a 16-gauge core biopsy nee-
dle instead of an 18-gauge core biopsy needle for
acquisition of a larger tissue sample. After each
biopsy, the site and size of the lymph node and
the number of biopsies were recorded. When
present, procedure-related complications were
also recorded. The patient was instructed to
compress the biopsy site manually for 30 min-
utes and was reexamined by sonography. If no
complication was detected, the patient was dis-
charged without any medication.
Tissue cores were stained with hematoxylin-
eosin, and, if needed, additional histochemical
and immunohistochemical stains were added.
Histologic diagnoses for the sonographically
guided core biopsies were reported as definitive,
suggestive but not definitive, or nondiagnostic.
The final diagnoses were determined by the
results of histologic examination from excision
biopsy when performed or by the clinical course
and sonographic follow-up for more than 12
months. When a lymph node diagnosed as
benign by sonographically guided core biopsy
regressed spontaneously or by subsequent man-
agement, the diagnosis made by the sonograph-
ically guided core biopsy was considered
correct. When a lymph node diagnosed as
benign by sonographically guided core biopsy
was unchanged or increased in size with subse-
quent management, excision biopsy was per-
formed.
The diagnostic yield, sensitivity, specificity,
accuracy, and complications of sonographically
guided core biopsy were evaluated with standard
methods using an Excel 2000 version 9.0 spread-
sheet (Microsoft Corporation, Redmond, WS).
The sonographically guided core biopsies were
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analyzed in 2 populations: (1) a population that
included all 155 biopsy results in which nondiag-
nostic and suggestive results were considered
incorrect and (2) a population in which nondiag-
nostic results were excluded and suggestive diag-
noses were regarded as incorrect diagnoses.
Results
The number of biopsies per patient ranged from
2 to 4 (mean, 2.5) biopsies. The location of the
lymph nodes sampled were in level I in 4
patients, level II in 21, level III in 14, level IV in 22,
and level V in 80. The precise location was not
recorded for 14 biopsies. The short diameter of
the nodes sampled ranged from 1.0 to 7 cm
(mean, 2.8 cm).
Histologic diagnosis could be made by sono-
graphically guided core biopsy in 146 (94%) of
the 155 patients. Table 1 details the histologic
diagnoses made by sonographically guided core
biopsy. In the 146 patients with histologic
results, histologic diagnoses were definitive in
144 patients and were highly suggestive in 2. The
2 highly suggestive results were Hodgkin lym-
phoma and tuberculosis, which were confirmed
as Hodgkin lymphoma and tuberculous lym-
phadenitis in the subsequent excision biopsies,
respectively. Nondiagnostic results were report-
ed in 9 patients. Seven biopsies were due to
inadequate amounts of tissue specimen, and 2
biopsies were reported to be fibroadipose tissue
only. Subsequent excision biopsies were per-
formed in 7 of the 9 patients. The results of
excision biopsy for the 7 patients were follicular
lymphoma in 1 patient, tuberculous lym-
phadenitis in 2, and reactive hyperplasia in 4. In
the 2 patients who had no excision biopsy, the
cervical lymphadenopathies resolved sponta-
neously within 1 month and were considered
benign.
Table 2 lists the histologic diagnoses of malig-
nant lymphadenopathy and their confirmed pri-
mary cancers or classification of lymphoma at
excision biopsies in the 146 sonographically
guided core biopsies. Among the 16 patients
with metastatic lymphadenopathy diagnosed by
sonographically guided core biopsy, primary
cancers were found through workup after core
biopsy in 14 patients. The histologic type of the





Figure 1. Sonograms during core needle biopsy using a dual-action semiauto-
matic core biopsy needle. A, Prefiring sonogram shows the guiding needle placed
at the target (arrows). B, The needle position before firing shows accurate place-
ment of the sample notch within the lesion (arrows). C, After firing, the outer
blade advances over the cutting notch (arrows).
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specimen obtained by core biopsy was consis-
tent with the primary tumor in 14 patients with
metastatic lymphadenopathy. One patient who
was reported as having metastatic lymphadenopa-
thy was confirmed as having anaplastic large cell
lymphoma at subsequent excision biopsy. In the
other reported as metastatic neuroendocrine car-
cinoma at core biopsy, primary cancer could not
be found despite a thorough workup, but subse-
quent excision biopsy revealed the same histologic
diagnosis as neuroendocrine carcinoma.
An exact subclassification of the lymphoma by
sonographically guided core biopsy could be
made in all 12 patients with non-Hodgkin lym-
phoma and in 2 of 4 patients with Hodgkin lym-
phoma. In 4 of 12 patients with non-Hodgkin
lymphoma and in 3 of 4 patients with Hodgkin
lymphoma, excision biopsies were performed and
revealed histologic subclassifications identical to
those by sonographically guided core biopsies.
Table 3 summarizes the sensitivity, specificity, and
accuracy of sonographically guided core needle
biopsy in differentiating benign from malignant
lymphadenopathy and in differentiating lym-
phoma from reactive hyperplasia.
Tuberculosis was definitively diagnosed by
sonographically guided core biopsy in 36 (92.3%)
of 39 patients. In 1 patient, a highly suggestive
diagnosis of tuberculous lymphadenitis was
reported and was confirmed by subsequent exci-
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Table 1. Histologic Diagnoses of the Adequately Sampled Cases by Core Biopsy and Confirmed Diagnoses
(n = 146)
Histologic Diagnosis (n) Age, y, Range (Mean) Confirmed Diagnosis (n [%])
Metastatic lymphadenopathy (16) 42–69 (51.6) Metastatic lymphadenopathy (15 [94]), 
anaplastic large cell lymphoma (1 [6])
Non-Hodgkin lymphoma (12) 13–82 (56.6) Non-Hodgkin lymphoma (12 [100])
Hodgkin lymphoma (4*) 13–58 (40.2) Hodgkin lymphoma (4 [100])
Tuberculosis (37†) 22–70 (41.6) Tuberculosis (37 [100])
Kikuchi disease (25) 16–43 (27) Kikuchi disease (25 [100])
Toxoplasmosis (1) 44 Toxoplasmosis (1 [100])
Nonspecific reactive hyperplasia (44) 15–62 (35.8) Reactive hyperplasia (44 [100])
Normal (7) 13–64 (37.1) Normal (6 [86%]), toxoplasmosis (1 [14])
*One was highly suggested at core biopsy and was confirmed by subsequent excision biopsy.
†One of 37 cases was highly suggested at core biopsy and was confirmed by subsequent excision biopsy. Two of the
total of 39 cases of tuberculous lymphadenitis showed nondiagnostic results at core biopsy.
Table 2. Histologic Diagnoses of Malignant Lymphadenopathy by Sonographically Guided Core Biopsy and
Confirmed Primary Cancer or Lymphoma at Excision Biopsy (n = 33)
Confirmed Primary Cancer or Classification 
Diagnosis at Core Needle Biopsy (n) of Lymphoma at Excision Biopsy (n)
Squamous carcinoma (6) Nasopharynx (4), lung (1), uterine cervix (1)
Poorly differentiated carcinoma (4) Lung (2), tongue base (1), hepatoma (1)
Adenocarcinoma (1) Uterine cervical adenocarcinoma (1)
Small cell carcinoma (1) Small cell lung cancer (1)
Neuroendocrine carcinoma (1) Primary cancer not found
Histiocytic sarcoma (1) Distal ileal histiocytic sarcoma (1)
Melanoma (1) Left finger melanoma (1)
Metastatic carcinoma (1) Anaplastic large cell lymphoma (1)
Diffuse large B cell lymphoma (9) Diffuse large B-cell lymphoma (2)
Burkitt lymphoma (1) Burkitt lymphoma (1)
Anaplastic large cell lymphoma (1) Anaplastic large cell lymphoma (1)
Precursor B cell lymphoma (1) Precursor B-cell lymphoma (1)
Mantle cell lymphoma (1) Mantle cell lymphoma (1)
Hodgkin lymphoma (4) Hodgkin lymphoma (3)
All histologic diagnoses of primary cancer were identical to those at core biopsies of lymph nodes except for 2 cases.
Primary cancer could not be found in 1 of those 2 cases, and anaplastic large cell lymphoma was confirmed at excision
biopsy in the other. 
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sion biopsy. Nondiagnostic results were reported
in 2 patients with tuberculous lymphadenitis,
which were confirmed as tuberculous lym-
phadenitis at subsequent excision biopsy.
Kikuchi disease was definitely diagnosed by
core biopsy in all 25 patients, among which 5
had the diagnosis confirmed by subsequent
excision biopsy, and 20 had the diagnosis con-
firmed by clinical and sonographic follow-up
for more than 12 months. Table 4 summarized
the sensitivity, specificity, and accuracy of sono-
graphically guided core biopsy for diagnosing
the cause of cervical lymphadenopathy, regard-
less of benignity or malignancy.
There were no procedure-related immediate or
delayed complications in any of the 155 patients.
Discussion
Fine-needle aspiration cytologic examination is
a safe and efficient procedure for diagnosis of
malignant cervical lymphadenopathy. However,
it has some limitations, even when performed in
optimum circumstances. It may be difficult to
distinguish low-grade lymphoma from reactive
hyperplasia, and the diagnosis of lymphoma is
not considered definitive.9 It may provide a pos-
sible diagnosis and indicate the need for nodal
excision for formal histologic assessment of the
entire nodal architecture.9,10 Fine-needle aspira-
tion cytologic examination also has a relatively
high rate of nondiagnostic results, which
sometimes are reported only as “negative for
malignancy” and which may be problematic in
management of cervical lymphadenopathy
because some benign diseases such as tubercu-
lous lymphadenitis requires specific antibiotic
treatment.
Sonographically guided core biopsy is a well-
established technique that is widely used in the
abdomen and breast.11 The major potential
complications of core biopsy are hemorrhage
and tumor seeding, which are unusual with
small-bore needles. Sonographically guided core
needle biopsy was not associated with an
increased incidence of local recurrence.11–13 A
few series reported its routine use in the head
and neck. This may be due to a reluctance to use
an automated biopsy device in an anatomic site
that contains numerous major vessels and
nerves. The use of sonographic guidance enables
us to accurately target the lesion and to avoid
injury to major vessels and nerves, resulting in
higher diagnostic accuracy and a lower com-
plication rate. Reported rates of hematoma
after sonographically guided core needle biopsy
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Table 3. Sensitivity, Specificity, and Accuracy of Sonographically Guided Core Biopsy of Cervical
Lymphadenopathy for Differentiating Benign From Malignant and Lymphoma From Nonspecific Reactive
Hyperplasia
Differentiation of Benign From Differentiation of Lymphoma From 
Malignant Lymphadenopathy Nonspecific Reactive Hyperplasia
Analysis Sensitivity, % Specificity, % Accuracy, % Sensitivity, % Specificity, % Accuracy, %
I (n = 155)* NA NA 93.5 NA NA 86.7
II (n = 146)† 96.8 100 99.3 93.7 100 98.3
*All biopsies were included in the analysis. Nondiagnostic results and highly suggestive diagnoses were regarded as incor-
rect diagnoses. NA indicates not applicable: sensitivity and specificity could not be calculated from these data.
†Nondiagnostic results were excluded in the analysis, and suggestive diagnoses were regarded as incorrect diagnoses.
Table 4. Sensitivity, Specificity, and Accuracy of Sonographically Guided Core Biopsy of Cervical
Lymphadenopathy for Diagnosing the Cause of Cervical Lymphadenopathy
Analysis Sensitivity, n (%) Specificity, n (%) Accuracy, n (%)
I (n = 155)* NA NA 143/155 (92.2)
II (n = 146)† 94/96 (97.9) 113/114 (99.1) 143/146 (97.9)
*All biopsies were included in the analysis. Nondiagnostic results and highly suggestive diagnoses were regarded as incor-
rect diagnoses. NA indicates not applicable: sensitivity and specificity could not be calculated from these data.
†Nondiagnostic results were excluded in the analysis, and suggestive diagnoses were regarded as incorrect diagnoses.
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of neck lymph nodes ranged from 0% to 1.2%
(0 of 82 patients to 3 minor hematomas in 247
patients).7,8 In our study, no postbiopsy
hematoma was detected. The use of color
Doppler sonography for detecting intervening
vessels and careful sonographic guidance
enabled us to prevent postbiopsy hematoma.
In this study, the results of sonographically
guided core biopsy were better in differentiating
benign causes from malignancy and in differen-
tiating lymphoma from reactive hyperplasia than
those of FNAC reported in literature.1–5 In addi-
tion, accurate subclassification of the lymphoma
was possible in all 12 patients with non-Hodgkin
lymphoma and 2 of 4 patients with Hodgkin lym-
phoma. The results of this study were consistent
with those in previous reports.7,8
Among the benign causes of unexplained cervi-
cal lymphadenopathy, tuberculous lymphadeni-
tis is important because timely and appropriate
antituberculosis medication is essential for treat-
ment. Therefore, prompt and accurate diagnosis
is necessary for tuberculous lymphadenitis. It can
be quite difficult to reliably diagnose tuberculous
lymphadenitis by clinical assessment and imag-
ing studies; therefore, cytopathologic, microbio-
logical, or histologic diagnosis is imperative.14–16
The sensitivity and accuracy of FNAC are not very
high for tuberculous lymphadenitis, mainly
because of nondiagnostic sampling.15,17,18 In our
study, the cases of tuberculous lymphadenitis
were easily diagnosed by sonographically guided
core biopsy. The patients with tuberculous lym-
phadenitis were appropriately treated without
delay or additional excision biopsy.
Kikuchi disease usually presents with unex-
plained cervical lymphadenopathy and is gener-
ally known as a self-limiting disease. It is not rare
in Asian populations. It is difficult to distinguish
Kikuchi disease from lymphoma or tuberculous
lymphadenitis clinically, and it is also difficult to
differentiate Kikuchi disease from lymphoma,
metastasis, or tuberculous lymphadenitis on the
basis of imaging studies in some cases.19 Because
FNAC also has low accuracy for Kikuchi disease,
excision biopsy is frequently required.20,21 On
core biopsy specimens, Kikuchi disease could be
diagnosed on the basis of the following histolog-
ic findings: (1) paracortical necrosis, (2) fibrinoid
necrosis, and (3) a mixture of variable propor-
tions of benign histiocytes. In this study, Kikuchi
disease was definitely diagnosed in all 25 patients
by sonographically guided core biopsy, which
prevented most of the patients from undergoing
unnecessary excision biopsy.
In this study, there were 9 cases of nondiagnos-
tic core biopsy results, of which 7 were confirmed
at subsequent excision biopsy. Among the 7
cases, 2 cases of tuberculous lymphadenitis were
heavily calcified lymph nodes, which may have
been the cause of the nondiagnostic results at
core biopsy. One case of follicular lymphoma,
which was very difficult to differentiate from
reactive hyperplasia, was confirmed by excision
biopsy. In the remaining 4 cases of reactive
hyperplasia, we infer that it was difficult to differ-
entiate it from low-grade lymphoma because of
limited tissue samples.
This study had a potential limitation in that the
clinical and sonographic follow-up results as well
as the results of excision biopsy were used as final
diagnoses. However, because all the lymph
nodes with benign results at sonographically
guided core biopsy that had not changed or had
increased in size during the follow-up were con-
firmed by excision biopsy, and because the
lymph nodes with benign results at sonographi-
cally guided core biopsy were regarded as benign
when they regressed spontaneously or by appro-
priate management, it was considerably reliable
that the diagnosis at sonographically guided core
biopsy was considered correct.
In conclusion, the results of this study reveal a
high yield and accuracy of sonographically guided
core biopsy for both benign and malignant causes
of cervical lymphadenopathy. Sonographically
guided core biopsy is a safe and efficient proce-
dure for diagnosing the cause of cervical lym-
phadenopathy and may obviate unnecessary
excision biopsy.
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